CV Sciences (CVSI) Capital Expenditures (QoQ) (2013 - 2026)
CV Sciences (CVSI) Capital Expenditures (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 133.33% |
| Mar 31, 2026 | -66.67% |
| Dec 31, 2025 | -18.18% |
| Sep 30, 2025 | -77.55% |
| Jun 30, 2025 | 22.50% |
| Mar 31, 2025 | 122.22% |
| Mar 31, 2021 | -95.72% |
| Dec 31, 2020 | 406.37% |
| Sep 30, 2020 | -162.09% |
| Jun 30, 2020 | 465.79% |
| Mar 31, 2020 | -93.25% |
| Dec 31, 2019 | 3,982.76% |
| Sep 30, 2019 | -158.00% |
| Jun 30, 2018 | -200.00% |
| Mar 31, 2018 | -69.17% |
| Dec 31, 2015 | 2,354,200.00% |
| Sep 30, 2015 | -99.99% |
| Jun 30, 2015 | -79.54% |
| Mar 31, 2015 | -26.38% |
| Dec 31, 2014 | -24.22% |